{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:05:17Z","timestamp":1791975917445,"version":"4.4.0"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:00:00Z","timestamp":1560297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0217597","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T17:31:50Z","timestamp":1560360710000},"page":"e0217597","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2236-3545","authenticated-orcid":true,"given":"Saskia","family":"Glasauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Altmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Hauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonita","family":"Brodhun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nita","family":"Perumal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,6,12]]},"reference":[{"key":"ref1","article-title":"Global tuberculosis report 2018","year":"2018"},{"key":"ref2","unstructured":"World Health Organisation. The End TB Strategy: World Health Organisation; 2014 [Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/tb\/strategy\/end-tb\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/tb\/strategy\/end-tb\/en\/<\/ext-link>."},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1183\/09031936.00214014","article-title":"Towards tuberculosis elimination: an action framework for low-incidence countries","volume":"45","author":"K Lonnroth","year":"2015","journal-title":"The European respiratory journal"},{"key":"ref4","unstructured":"The review on antimicrobial resistance. Tackling drug-resistant infections globally: final report and recommendations 2016 [Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/amr-review.org\/sites\/default\/files\/160525_Final%20paper_with%20cover.pdf\" xlink:type=\"simple\">https:\/\/amr-review.org\/sites\/default\/files\/160525_Final%20paper_with%20cover.pdf<\/ext-link>."},{"issue":"11","key":"ref5","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.11.20737","article-title":"M S. Drug-resistance\u2014a challenge for tuberculosis control in the European Union and European Economic Area","volume":"19","author":"M van der Werf","year":"2014","journal-title":"Euro Surveill"},{"issue":"9813","key":"ref6","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S0140-6736(11)61428-1","article-title":"Tackling the spread of drug-resistant tuberculosis in Europe","volume":"379","author":"I Abubakar","year":"2012","journal-title":"Lancet (London, England)"},{"key":"ref7","year":"2018"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","DOI":"10.2807\/ese.15.11.19519-en","article-title":"Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area","volume":"15","author":"C K\u00f6dm\u00f6n","year":"2010","journal-title":"Euro Surveill"},{"key":"ref9","unstructured":"World Health Organization. Basic facts on tuberculosis (TB) in the WHO European Region 2018 [Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.euro.who.int\/en\/health-topics\/communicable-diseases\/tuberculosis\/data-and-statistics\" xlink:type=\"simple\">http:\/\/www.euro.who.int\/en\/health-topics\/communicable-diseases\/tuberculosis\/data-and-statistics<\/ext-link>."},{"key":"ref10","year":"2018"},{"issue":"11","key":"ref11","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.11.20742","article-title":"Molecular surveillance of multi- and extensively drugresistant tuberculosis transmission in the European Union from 2003 to 2011","volume":"19","author":"J de Beer","year":"2014","journal-title":"Euro Surveill"},{"key":"ref12","year":"2014"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.11.20738","article-title":"Extent and origin of resistance to antituberculosis drugs in the Netherlands, 1993 to 2011","volume":"19","author":"C Ruesen","year":"2014","journal-title":"Euro Surveill"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.11.20736","article-title":"Transmission of multidrug-resistant tuberculosis in a low-incidence setting, Switzerland, 2006 to 2012","volume":"19","author":"A Somoskovi","year":"2012","journal-title":"Euro Surveill"},{"key":"ref15","year":"2018"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.10.20733","article-title":"Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012","volume":"19","author":"MJ van der Werf","year":"2014","journal-title":"Euro Surveill"},{"key":"ref17","article-title":"Guidelines for Clinical and Operational Management of Drug-Resistant Tuberculosis","author":"J Caminero","year":"2013"},{"key":"ref18","year":"2016"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1055\/s-0043-105954","article-title":"S2k-Leitlinie: Tuberkulose im Erwachsenenalter","volume":"71","author":"T Schaberg","year":"2017","journal-title":"Pneumologie"},{"issue":"A5544","key":"ref20","article-title":"The Reliability of Rifampicin Resistance Identified on Xpert MTB\/RIF as a Proxy for Multidrug-Resistant Tuberculosis (MDR-TB) in a Reference Center for MDR-TB in Rio de Janeiro","volume":"197","author":"A Santos","year":"2018","journal-title":"Brazil Am J Respir Crit Care Med"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijmyco.2016.02.004","article-title":"High prevalence of multidrug-resistant tuberculosis among patients with rifampicin resistance using GeneXpert Mycobacterium tuberculosis\/rifampicin","volume":"5","author":"J Boakye-Appiah","year":"2016","journal-title":"Ghana. Int J Mycobacteriol"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","DOI":"10.1089\/mdr.2017.0114","article-title":"Rifampicin Resistance and Multidrug-Resistant Tuberculosis Detection Using Xpert MTB\/RIF in Wuhan, China: A Retrospective Study","volume":"24","author":"H Huang","year":"2018","journal-title":"Microb Drug Resist"},{"key":"ref23","article-title":"Using the Xpert MTB\/RIF assay to detect pulmonary and extrapulmonary tuberculosis and rifampicin resistance in adults and children","year":"2013"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10096-017-3079-4","article-title":"The reliability of rifampicin resistance as a proxy for multidrug-resistant tuberculosis: a systematic review of studies from Iran","volume":"37","author":"M Nasiri","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5588\/ijtld.11.0445","article-title":"Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis","volume":"16","author":"S Smith","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jiph.2012.03.005","article-title":"Primary anti-tuberculous drugs resistance of pulmonary tuberculosis","volume":"5","author":"AM Asaad","year":"2012","journal-title":"Southwestern Saudi Arabia. J Infect Public Health"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1016\/j.ijid.2008.11.027","article-title":"First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran\u2014eight years of surveillance","volume":"13","author":"M Shamaei","year":"2009","journal-title":"Int J Infect Dis"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.300.4.405","article-title":"Tuberculosis among foreign-born persons in the United States","volume":"300","author":"KP Cain","year":"2008","journal-title":"Jama"},{"issue":"2","key":"ref29","first-page":"243","article-title":"First- and second-line drug resistance patterns among previously treated tuberculosis patients","volume":"14","author":"CN Paramasivan","year":"2010","journal-title":"India. Int J Tuberc Lung Dis"},{"issue":"15","key":"ref30","doi-asserted-by":"crossref","first-page":"e3336","DOI":"10.1097\/MD.0000000000003336","article-title":"Epidemiological Trends of Drug-Resistant Tuberculosis in China From 2007 to 2014: A Retrospective Study","volume":"95","author":"XC He","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"e0197737","DOI":"10.1371\/journal.pone.0197737","article-title":"Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia","volume":"13","author":"EA Mesfin","year":"2018","journal-title":"PLoS One"},{"key":"ref32","article-title":"Gesetz zur Modernisierung der epidemiologischen \u00dcberwachung \u00fcbertragbarer Krankheiten","author":"Deutscher Bundestag","year":"2017"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2807\/esm.11.04.00614-en","article-title":"<email xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:type=\"simple\">SurvNet@RKI<\/email>\u2014a multistate electronic reporting system for communicable diseases","volume":"11","author":"D Faensen","year":"2006","journal-title":"Euro Surveill"},{"key":"ref34","article-title":"Leitfaden zur \u00dcbermittlung von Fallberichten zur Tuberkulose","year":"2004"},{"issue":"9851","key":"ref35","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(12)61069-1","article-title":"Unexpected high levels of multidrug-resistant tuberculosis present new challenges for tuberculosis control","volume":"380","author":"S Hoffner","year":"2012","journal-title":"Lancet (London, England)"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1469-0691.2007.01813.x","article-title":"Antimicrobial Susceptibility Testing of Mycobacterium Tuberculosis (EUCAST document E.DEF 8.1)\u2014Report of the Subcommittee on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)","volume":"13","author":"F Drobniewski","year":"2007","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5588\/ijtld.11.0266","article-title":"Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosis","volume":"16","author":"C Pierre-Audigier","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0031-1291619","article-title":"Empfehlungen zur Therapie, Chemopr\u00e4vention und Chemoprophylaxe der Tuberkulose im Erwachsenen- und Kindesalter","volume":"66","author":"T Schaberg","year":"2012","journal-title":"Pneumologie"},{"key":"ref39","unstructured":"RStudio Team. RStudio: Integrated Development for R. Boston, MA: RStudio, Inc.; 2015."},{"issue":"8","key":"ref40","doi-asserted-by":"crossref","first-page":"e2399","DOI":"10.1371\/journal.pntd.0002399","article-title":"Differences in primary sites of infection between zoonotic and human tuberculosis: results from a worldwide systematic review","volume":"7","author":"S Durr","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3201\/eid2103.141539","article-title":"Epidemiology of human Mycobacterium bovis disease, California, USA, 2003\u20132011","volume":"21","author":"M Gallivan","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"249","key":"ref42","article-title":"factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia","volume":"18","author":"B Demile","year":"2018","journal-title":"Risk"},{"issue":"422","key":"ref43","article-title":"Risk factors for the occurrence of multi-drug resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia","volume":"18","author":"F Desissa","year":"2018","journal-title":"BMC Public Health"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/thx.2005.045963","article-title":"Risk factors for multidrug resistant tuberculosis in Europe: a systematic review","volume":"61","author":"A Faustini","year":"2006","journal-title":"Thorax"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4236\/jtr.2014.23014","article-title":"Risk Factors for Drug-Resistant Tuberculosis","volume":"2","author":"M Gomes","year":"2014","journal-title":"Tuberc Res"},{"issue":"10","key":"ref46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/IDR.S126274","article-title":"Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: a case-control study","author":"A Workicho","year":"2017","journal-title":"Infect Drug Resist"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cmi.2016.09.009","article-title":"Multidrug-resistant tuberculosis and migration to Europe","volume":"23","author":"S Hargreaves","year":"2017","journal-title":"Clin Microbiol Infect"},{"issue":"28","key":"ref48","article-title":"Tuberculosis in Greece: bacteriologically confirmed cases and antituberculosis drug resistance","volume":"15","author":"D Papaventsis","year":"2010","journal-title":"Euro Surveill"},{"issue":"9","key":"ref49","first-page":"964","article-title":"Risk factors for drug-resistant tuberculosis among non-US-born persons in New York City","volume":"9","author":"C Clark","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9","key":"ref50","first-page":"954","article-title":"In the European Union, TB patients from former Soviet countries have a high risk of multidrug resistance","volume":"10","author":"D Falzon","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"issue":"340","key":"ref51","article-title":"Trend of microbiologically-confirmed tuberculosis in a low-incidence setting with high immigration rates","volume":"14","author":"G Lombardi","year":"2014","journal-title":"BMC Public Health"},{"issue":"1171","key":"ref52","article-title":"Rates and risk factors for drug resistance tuberculosis in Northeastern China","volume":"13","author":"Q Liu","year":"2013","journal-title":"BMC Public Health"},{"issue":"110","key":"ref53","article-title":"Epidemiology of anti-tuberculosis drug resistance in a chinese population: current situation and challenges ahead","volume":"11","author":"Y Shao","year":"2011","journal-title":"BMC Public Health"},{"issue":"4","key":"ref54","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1473-3099(18)30004-5","article-title":"A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study","volume":"18","author":"TM Walker","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41479-018-0049-2","article-title":"Rapid molecular assays for detection of tuberculosis","volume":"10","author":"R Eddabra","year":"2018","journal-title":"Pneumonia (Nathan Qld)"},{"issue":"Suppl 2","key":"ref56","first-page":"5","article-title":"Predictors of multidrug resistant tuberculosis among adult patients at Saint Peter Hospital Addis Ababa, Ethiopia","volume":"25","author":"M Dessalegn","year":"2016","journal-title":"Pan Afr Med J"},{"issue":"1","key":"ref57","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12941-018-0283-8","article-title":"Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study","volume":"17","author":"D Gobena","year":"2018","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref58","year":"2010"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0217597","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T15:22:18Z","timestamp":1663687338000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0217597"}},"subtitle":[],"editor":[{"given":"Alejandro","family":"Escobar-Guti\u00e9rrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,6,12]]},"references-count":58,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0217597","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,12]]}}}